CM Life Sciences II Inc. (CMII) Research

CM Life Sciences II Inc. currently conducts no substantial business operations. Its primary goal is to complete a strategic business combination, which could involve a merger, stock or asset acquisition, or reorganization, with one or more enterprises within the life sciences field. The company was founded in 2020 and has its headquarters in New York City.

Market snapshot

Symbol
CMII
Price
$10.63
Day change
-5.93%
Market cap
$2.0B
52-week range
10.5-11.3
Sector
Financial Services
Industry
Shell Companies

Peer companies

  • Apex Treasury Corporation Class A (APXT)
  • Trump Media & Technology Group Corp. (DJT)
  • dMY Technology Group, Inc. III (DMYI)
  • Fortress Value Acquisition Corp. II (FAII)
  • Grindr Inc. (GRND)
  • Mudrick Capital Acquisition Corporation II (MUDS)
  • Navitas Semiconductor Corporation (NVTS)
  • Star Peak Corp II (STPC)

Recent insider activity

  • COLUMBUS CIRCLE 2 SPONSOR Corp LLC — P-Purchase (265000 shares) on 2026-02-12
  • COLUMBUS CIRCLE 2 SPONSOR Corp LLC — trade (7666667 shares) on 2026-02-10
  • CMLS Holdings II LLC — trade (6900000 shares) on 2021-02-22
  • Cox Troy — trade (25000 shares) on 2021-02-22

Open CM Life Sciences II Inc. (CMII) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.